Citation Impact
Citing Papers
Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidney
2009 StandoutNobel
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Acromegaly
2006 Standout
The locus coeruleus–noradrenergic system: modulation of behavioral state and state-dependent cognitive processes
2003 Standout
Variations of Human Adrenomedullin Gene and Its Relation to Cardiovascular Diseases
2003
Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice
2006 StandoutNobel
CDK inhibitors: positive and negative regulators of G1-phase progression
1999 Standout
The p16INK4a/CDKN2A tumor suppressor and its relatives
1998
The RB and p53 pathways in cancer
2002 Standout
Dissociated central and peripheral release of vasopressin, but not oxytocin, in response to repeated swim stress: New insights into the secretory capacities of peptidergic neurons
1998
The effect of obesity on the outcome of infertility management in women with polycystic ovary syndrome
2003
Cyclin D and cyclin E expression in normal and adenomatous pituitary
2000
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Neurophysiology and neuropharmacology of hypothalamic magnocellular neurons secreting vasopressin and oxytocin
1991
Neonatal estrogenic exposure suppresses PTEN-related endometrial carcinogenesis in recombinant mice
2006 StandoutNobel
Interruption of central noradrenergic pathways and morphine withdrawal excitation of oxytocin neurones in the rat
1998
Cushing's syndrome
2015 Standout
Autophagy as a cell death and tumor suppressor mechanism
2004 Standout
Preferential loss of Death Associated Protein kinase expression in invasive pituitary tumours is associated with either CpG island methylation or homozygous deletion
2002
Molecular defects in the pathogenesis of pituitary tumours
2003
CDKN2A Mutation Analysis, Protein Expression, and Deletion Mapping of Chromosome 9p in Conventional Clear-Cell Renal Carcinomas
2001
Head and neck cancer
2008 Standout
Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
2005 Standout
Novel Patterns of Gene Expression in Pituitary Adenomas Identified by Complementary Deoxyribonucleic Acid Microarrays and Quantitative Reverse Transcription-Polymerase Chain Reaction1
2001
Something fishy in the rat brain: molecular genetics of the hypothalamo-neurohypophysial system
1998 StandoutNobel
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders
1999
Cancer genes and the pathways they control
2004 Standout
MEDICAL TREATMENT OF PROLACTINOMAS
1999
Prevalence of an immunological LH β‐subunit variant in a UK population of healthy women and women with polycystic ovary syndrome
1995
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
2011 Standout
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
The cornified envelope: a model of cell death in the skin
2005 Standout
Hypoxia Inhibits G1/S Transition through Regulation of p27 Expression
2001 StandoutNobel
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Transglutaminases: crosslinking enzymes with pleiotropic functions
2003 Standout
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
2008 Standout
Long-term consequences of polycystic ovary syndrome: Results of a 31 year follow-up study
2000
p16(MTS-1/CDKN2/INK4a) in Cancer Progression
2001
Structure and Organization of the Human Transglutaminase 3 Gene: Evolutionary Relationship to the Transglutaminase Family
1994
Corticotroph carcinoma of the pituitary: a clinicopathological study
2002
The VHL/HIF axis in clear cell renal carcinoma
2012 StandoutNobel
Genetics and Proteomics of Pituitary Tumors
2005
Nutrition, hormones, and breast cancer: Is insulin the missing link?
1996
The 2004 World Health Organization classification of pituitary tumors: What is new?
2005
Polycystic Ovary Syndrome
2005 Standout
Genomic instability — the engine of tumorigenesis?
2003
Insulin and insulin resistance:
2004 Standout
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
2008 Standout
Effects of intracerebroventricular infusions of naltrexone and phentolamine on central and peripheral oxytocin release and on maternal behaviour induced by vaginocervical stimulation in the ewe
1989
Isolation of a cDNA clone and localization of the human glutathione S‐transferase 3 genes to chromosome bands 11q13 and 12q13‐14
1989
Crosstalk in NF-κB signaling pathways
2011 Standout
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio
2001
Cushing's syndrome
2006 Standout
Biobehavioral responses to stress in females: Tend-and-befriend, not fight-or-flight.
2000 Standout
Polycystic ovary syndrome
2016 Standout
The Glut athione S-Transferase Supergene Family: Regulation of GST and the Contribution of the lsoenzymes to Cancer Chemoprotection and Drug Resistance Part I
1995 Standout
Physiological pathways regulating the activity of magnocellular neurosecretory cells
1999
Activation of the noradrenergic system facilitates an attentional shift in the rat
1990
The Role of Oxytocin Release in the Mediobasal Hypothalamus of the Sheep in Relation to Female Sexual Receptivity
1993
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
ROS signalling in the biology of cancer
2017 Standout
The epidemiology and genetics of pituitary adenomas
2009
p27kip1: A Multifunctional Cyclin-Dependent Kinase Inhibitor with Prognostic Significance in Human Cancers
1999
Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma?
2006
Insulin resistance in polycystic ovary syndrome is associated with defective regulation of ERK1/2 by insulin in skeletal muscle in vivo
2008
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
2006 Standout
Approach to the Cushing's Disease Patient With Persistent/Recurrent Hypercortisolism After Pituitary Surgery
2013
Localization of oxytocin receptor messenger ribonucleic acid in the rat brain.
1993
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Selective Loss of MEG3 Expression and Intergenic Differentially Methylated Region Hypermethylation in the MEG3/DLK1 Locus in Human Clinically Nonfunctioning Pituitary Adenomas
2008
Adrenomedullin gene expression differences in mice do not affect blood pressure but modulate hypertension-induced pathology in males
2007 StandoutNobel
The Insulin-Related Ovarian Regulatory System in Health and Disease
1999
Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review.
2002
Idazoxan, an α-2 antagonist, facilitates memory retrieval in the rat
1989
Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism.
1996
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
1997 Standout
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
Familial Isolated Pituitary Adenomas (FIPA) and the Pituitary Adenoma Predisposition due to Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene
2013
The Molecular Pathogenesis of Corticotroph Tumors
1999
Cells Lacking IKKα Show Nuclear Cyclin D1 Overexpression and a Neoplastic Phenotype: Role of IKKα as a Tumor Suppressor
2011
Pituitary Carcinoma: A Clinicopathological Review
2005
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
The Oxytocin Receptor System: Structure, Function, and Regulation
2001 Standout
Optimizing Release From Peptide Hormone Secretory Nerve Terminals
1988
AN INTEGRATIVE THEORY OF LOCUS COERULEUS-NOREPINEPHRINE FUNCTION: Adaptive Gain and Optimal Performance
2005 Standout
Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome.
1995
Works of John Bicknell being referenced
Loss of expression of the growth inhibitory gene GADD45γ, in human pituitary adenomas, is associated with CpG island methylation
2003
Insulin sensitivity in women with polycystic ovary syndrome: relationship to hyperandrogenemia
1994
Contribution of the Region Anterior and Ventral to the Third Ventricle to Opiate Withdrawal Excitation of Oxytocin Secretion
1992
Pituitary tumours are multiclonal from the outset: evidence from a case with dural metastases
2002
Tumour Suppressor Genes in the Pathogenesis of Human Pituitary Tumours
1997
Sequence analysis and transcript expression of the MEN1 gene in sporadic pituitary tumours
1999
Opioid-Noradrenergic Interactions in the Neurohypophysis
1988
Opioid-Noradrenergic Interactions in the Neurohypophysis
1988
Hypermethylation of thep16/CDKN2A/MTS1 gene and loss of protein expression is associated with nonfunctional pituitary adenomas but not somatotrophinomas
1999
Different patterns of allelic loss (loss of heterozygosity) in recurrent human pituitary tumors provide evidence for multiclonal origins.
2000
Hypermethylation of the p16/CDKN2A/MTSI gene and loss of protein expression is associated with nonfunctional pituitary adenomas but not somatotrophinomas.
1999
Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors.
1999
Chromosome 13q deletion mapping in pituitary tumors: infrequent loss of the retinoblastoma susceptibility gene (RB1) locus despite loss of RB1 protein product in somatotrophinomas.
1999
Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 genes.
1997